General Overview of Neuropeptides
Tomas Hökfelt, Zhi-Qing David Xu, Christian Broberger, Tiejun Sten Shi and
Xu Zhang
Department of Neuroscience
Karolinska Institute
S-171 77 Stockholm, Sweden
phone: (46)(8) 728 7070
fax: (46)(8) 33 16 92
tomas.hokfelt@neuro.ki.se
REFERENCES
1. Acher R, Chauvet
J, Chauvet MT. Man and the chimaera. In: Ivell R, Russell JA (eds.) Oxytocin: cellular and molecular approaches
in medicine and research. Adv. Exp. Med. Biol. 395. New York: Plenum, 1995;
615-627
2. Advenier C,
Rouissi N, Nguyen QT, Emonds-Alt X, Breliere JC, Neliat G, Naline E, Regoli
D. Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide
antagonist. Biochem. Biophys. Res. Commun.
1992; 184: 1418-1424.
3. Appell KC,
Fragale BJ, Loscig J, Singh S, Tomczuk BE. Antagonists that demonstrate species
differences in neurokinin-1 receptors. Mol.
Pharmacol. 1992; 4: 772-778.
4. Augood SJ,
Kiyama H, Faull RLM, Emson PC. Differential effects of acute dopaminergic D1
and D2 antagonists on proneurotensin mRNA expression in rat striatum. Mol. Brain Res. 1991; 9: 341-346.
5. Balasubramaniam
AA. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 1997; 18: 445-457.
6. Baraban SC,
Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD. Knock-out mice reveal
a critical antiepileptic role for neuropeptide Y. J. Neurosci. 1997; 17: 8927-8936.
7. Barrett JE,
Linden MC, Holloway HC, Yu MJ, Howbert JJ. Anxiolytic-like effects of the CCK-B
antagonists LY262691, LY262684, and LY247348 on punished responding of squirrel
monkeys. Soc. Neurosci. Abstr. 1991;
17: 1063.
8. Battey JF,
Way JM, Corjay MH, Shapira H, Kusano K, Harkins R, Wu JM, Slattery T, Mann E,
Feldmann RJ. Molecular cloning of the bombesin/gastrin-releasing peptide receptor
from Swiss 3T3 cells. Proc. Natl. Acad.
Sci. USA 1991; 88: 395-399.
9. Belin MF, Nanopoulos
D, Didier D, Aguera M, Steinbusch H, Verhofstad A, Maitre M, Pujol JF. Immunohistochemical
evidence for the presence of gamma-aminobutyric acid and serotonin in one nerve
cell. A study on the raphe nuclei of the rat using antibodies to glutamate decarboxylase
and serotonin. Brain Res. 1983; 275: 329-339.
10. Betancur C,
Azzi M, Rostène W. Nonpeptide antagonists of neuropeptide receptors: tools for
research and therapy. Trends Physiol.
Sci. 1997; 18: 372-386.
11. Birnbaumer
M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P, Rosenthal
W. Molecular cloning of the receptor for human antidiuretic hormone. Nature 1992; 357: 333-335.
12. Bloch B, Guitteny
AF, Normand E, Chouham S. Presence of neuropeptide messenger RNAs in neuronal
processes. Neurosci. Lett. 1990; 109:
259-264.
13. Bloom FE.
Future directions and goals in basic psychopharmacology and neurobiology. In:
Meltzer HY (ed.) Psychopharmacology. The
Third Generation of Progress. New York: Raven Press, 1987; 1685-1689
14. Bloom FE,
Caron M, Changeux J-P, Crabbe JC, Crawley JN, Frankel WN, Morgan JI, Nestler
EJ, Paigen K, Takahashi JS, Tonegawa S. Knockouts and mutants: genetically dissecting
brain and behavior. Brain Res. 1998;
809: A1-A33.
15. Bloom FE,
Kupfer DJ (eds.). Psychopharmacology. The Fourth Generation of Progress. New
York: Raven Press, 1995.
16. Bock MG, DiPardo
RM, Evans BE, Rittle KE, Whitter WL, Veber DE, Anderson PS, Freidinger RM. Benzodiazepine
gastrin and brain cholecystonkinin receptor ligands: L-365,260. J.
Med. Chem. 1989; 32: 13-16.
17. Bradwejn J,
Koszycki D, Paradis M, Reece P, Hinton J, Sedman A. Effect of CI-988 on cholecystokinin
tetrapeptide-induced panic symptoms in healthy volunteers. Biol. Psychiatry 1995; 38: 742-746.
18. Broberger
C, De Lecea L, Sutcliffe JG, Hökfelt T. Hypocretin/orexin- and melanin-concentrating
hormone-expressing cells form distinct populations in the rodent lateral hypothalamus:
relationship to the neuropeptide Y and
agouti gene-related protein systems. J. Comp. Neurol. 1998; 402: 460-474.
19. Burbach JPH,
de Wied D (eds.). Brain Functions of Neuropeptides. A Current View. Carnforth,
New York: The Parthenon Publishing Group, 1993.
20. Bzdega T,
Chin H, Kim H, Jung HH, Kozak CA, Klee WA. Regional expression and chromosomal
localization of the d opiate receptor gene. Proc. Natl.
Acad. Sci. USA 1993; 90: 9305-9309.
21. Cao YQ, Manthy
PW, Carlson EJ, Gillespie A-M, Epstein CJ, Basbaum AI. Primary afferent tachykinins
are required to experience moderate to intense pain. Nature 1998; 392: 390-394.
22. Castel MN,
Morino P, Dagerlind Å, Hökfelt T. Upregulation of neurotensin mRNA in the rat
striatum after acute methamphetamine treatment. Eur. J. Neurosc. 1994; 6: 646-656.
23. Castel MN,
Morino P, Frey P, Terenius L, Hökfelt T. Immunohistochemical evidence for a
neurotensin striatonigral pathway in the rat. Neuroscience 1993; 55: 833-847.
24. De Felipe
C, Herrero JF, O'Brian JA, Palmer JA, Doyle CA, Smith AJH, Laird JMA, Belmonte
C, Cervero F, Hunt SP. Altered nociception, analgesia and aggression in mice
lacking the receptor for substance P. Nature
1998; 392: 394-397.
25. De Felipe
C, Pinnock RD, Hunt SP. Modulation of chemotropism in the developing spinal
cord by substance P. Science 1995;
267: 899-902.
26. De la Pena
P, Delgado LM, Del Camino D, Barros F. Cloning and expression of the thyrotropin-releasing
hormone receptor from GH3 rat anterior pituitary cells. Biochem. J. 1992; 15: 891-899.
27. De Lecea L,
Kilduff TS, Peyron C, Gao Z-B, Foye PE, Danielson PE, Fukuhara C, Battenberg
ELF, Gautvik VT, Bartlett II FS, Frankel WN, van den Pol AN, Bloom FE, Gautvik
KM, Sutcliffe JG. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory
activity. Proc. Natl. Acad. Sci. USA
1998; 95: 322-327.
28. Denis-Donini
S. Expression of dopaminergic phenotypes in the mouse olfactory bulb induced
by the calcitonin gene-related peptide. Nature
1989; 339: 701-703.
29. Deutch AY,
Zahm DS. The current status of neurotensin-dopamine interactions. Ann. N.Y. Acad. Sci. 1992; 668: 232-252.
30. Dooley CT,
Chung NN, Wilkes BC, Schiller PW, Bidlack JM, Pasternak GW, Houghten RA. An
all D-amino acid opioid peptide with central analgesic activity from a combinatorial
library. Science 1994; 266: 2019-2022.
31. Douglass J,
McKinzie AA, Couceyro P. PCR differential display identifies a rat brain mRNA
that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 1995; 15: 2471-2481.
32. Du Vigneaud
V, Ressler C, Trippett S. The sequence of amino acids in oxytocin, with a proposal
for the structure of oxytocin. J. Biol.
Chem. 1953; 205: 949-957.
33. Durieux CR-G,
Bergeron F, Ducos B, Corringer PJ, Roques BP. (3H)pBC 264, a suitable probe
for studying CCK-B receptors: binding characteristics in rodent brains and comparison
with (3H)SNF
8702. Mol. Pharmacol. 1992; 41: 1089-1095.
34. Elde R, Arvidsson
U, Riedl M, Vulchanova L, Lee J-H, Dado R, Nakano A, Chakrabarti S, Zhang X,
Loh HH, Law P-Y, Hökfelt T, Wessendorf M. Distribution of neuropeptide receptors.
New Views of peptidergic neurotransmission made possible by antibodies to opioid
receptors. Ann. N.Y. Acad. Sci. 1995;
757: 390-404.
35. Elias CF,
Saper CB, Maratos-Filier E, Tritos NA, Lee C, Kelly J, Tatro JB, Hoffman GE,
Ollmann MM, Barsh GS, Sakurai T, Yanagisawa M, Elmquist JK. Chemically defined
projections linking the mediobasal hypothalamus and the lateral hypothalamic
area. J. Comp. Neurol. 1998; 402:
442-459.
36. Erickson JC,
Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice
by the loss of neuropeptie Y. Science
1996; 274: 1704-1707.
37. Eva C, Keinänen
K, Monyer H, Seeburg P, Sprengel R. Molecular cloning of a novel G protein-coupled
receptor that may belong to the neuropeptide receptor family. FEBS Letters 1990; 271: 81-84.
38. Evans BE,
Bock MG, Rittle KE, DiPardo RM, Whitter WL, Veber DF, Anderson PS, Freidinger
RM. Design of potent, orally effective, nonpeptidal antagonists of the peptide
hormone cholecystokinin. Proc. Natl. Acad.
Sci. USA 1986; 83: 4918-4922.
39. Evans CJ,
Keith DEJ, Morrison H, Magendzo K, Edwards RH. Cloning of a delta opioid receptor
by functional expression. Science
1992; 258: 1952-1955.
40. Fontaine B,
Klarsfeld A, Changeux J-P. Calcitonin gene-related peptide and muscle activity
regulate acetylcholine receptor alpha-subunit mRNA levels by distinct intracellular
pathways. J. Cell Biol. 1987; 105:
1337-1342.
41. Garret C,
Carruette A, Fardin V, Moussaoui S, Peyronel J-F, Blanchard J-C, Laduron PM.
Pharmacological properties of a potent and selective nonpeptide substance P
antagonist. Proc. Natl. Acad. Sci. USA
1991; 88: 10208-10212.
42. Gerfen CR,
Engber PM, Mahan LC, Susel Z, Chase TN, Monsma FJJ, Sibley DR. D1 and D2 dopamine receptor-regulated
gene expression on striatonigral and striatopallidal neurons. Science 1990; 250: 1429-1432.
43. Gerfen CR,
McGinty JF, Young WSI. Dopamine differentially regulates dynorphin, substance
P, and enkephalin expression in striatal neurons: in situ hybridization histochemical
analysis. J. Neuroscience 1991; 11:
1016-1031.
44. Gerfen CR,
Wilson CJ. The basal ganglia. In: Swanson LW, Björklund A, Hökfelt T (eds.)
Handbook of Chemical Neuroanatomy., Vol. 12.
Integrated Systems of the CNS. Part III. Amsterdam: Elsevier, 1996; 371-468
45. Giaid A, Gibson
SJ, Ibrahim BN, Legon S, Bloom SR, Yanagisawa M, Masaki T, Varndell IM, Polak
JM. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of
the human spinal cord and dorsal root ganglia. Proc. Natl. Acad. Sci. USA 1989; 86: 7634-7638.
46. Grady EF,
Gamp PD, Jones E, Baluk P, McDonald DM, Payan DG, Bunnett NW. Endocytosis and
recycling of neurokinin receptors in enteric neurons. Neuroscience 1996; 75: 1239-1254.
47. Graybiel AM.
Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 1990; 13: 244-254.
48. Green KA,
Falconer SWP, Cottreil GA. The neuropeptide Phe-Met-Arg-Phe-NH2 (FMRF
amide) directly gates two ion channels in an identified helix neurone. Pflügers. Arch. - Europ. J. Physiol. 1994;
428: 232-240.
49. Gressens P,
Hill JM, Gozes I, Fridkin M, Brenneman DE. Growth factor function of vasoactive
intestinal peptide in whole cultured mouse embryos. Nature 1993; 362: 155-158.
50. Gressens P,
Paindaveine B, Hill JM, Evrard P, Brenneman DE. Vasoactive intestinal peptide
shortens both G1 and S phases of neural cell cycle in whole postimplantation
cultured mouse embryos. Eur. J. Neurosci.
1998; 10: 1734-1742.
51. Grimmelikhuijzen
CJ, Leviev I, Carstensen K. Peptides in the nervous systems of cnidarians: structure,
function, and biosynthesis. Int. Rev.
Cytol. 1996; 167: 37-89.
52. Gully D, Canton
M, Boigegrain R, Jeanjean F, Molimard J-C, Poncelet M, Gueudet C, Heaulme M,
Leyris R, Brouard A, Pelaprat D, Labbé-Jullié C, Mazella J, Soubrié P, Maffrand
J-P, Rostène W, Kitabgi P, Le Fur G. Biochemical and pharmacological profile
of a potent and selective nonpeptide antagonist of the neurotensin receptor.
Proc. Natl. Acad. Sci. USA 1993; 90:
65-69.
53. Harrison MB,
Wiley RG, Wooten GF. Selective localization of striatal D1 receptors to striatonigral
neurons. Brain Res. 1990; 528: 317-322.
54. Herbert J.
Peptides in the limbic system: neurochemical codes for co-ordinated adaptive
responses to behavioural and physiological demand. Prog. Neurobiol. 1994; 41: 723-791.
55. Hershey AD,
Krause JE. Molecular characterization of a functional cDNA encoding the rat
substance P receptor. Science 1990;
247: 958-962.
56. Herzog H,
Hort YJ, Ball HJ, Hayes G, Shine J, Selbie LA. Cloned human neuropeptide Y receptor
couples to two different second messenger systems. Proc. Natl. Acad. Sci. USA 1992; 89: 5794-5798.
57. Hinuma S,
Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano
T, Matsumoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, Fujino M. A prolactin-releasing
peptide in the brain. Nature 1998;
393: 272-276.
58. Hokfelt T.
Neuropeptides in perspective : The last ten years. Neuron 1991; 7: 867-879.
59. Hökfelt T,
Castel M-N, Morino P, Zhang X, Dagerlind Å. General overview of neuropeptides.
In: Bloom FE, Kupfer DJ (eds.) Psychopharmacology;
The Fourth Generation of Progress. New York: Raven Press, 1995; 483-492
60. Hökfelt T,
Wiesenfeld-Hallin Z, Villar M, Melander T. Increase of galanin-like immunoreactivity
in rat dorsal root ganglion cells after peripherl axotomy. Neurosci. Lett. 1987; 83: 217-220.
61. Hökfelt T,
Xu Z-QD, Shi T-J, Holmberg K, Zhang X. Galanin in ascending systems: Focus on
coexistence with 5-hydroxytryptamine and noradrenaline. Ann. N.Y. Acad. Sci. 1998; 863: 252-263.
62. Hökfelt T,
Zhang X, Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons
following axotomy and its functional implications. Trends Neurosci. 1994; 17: 22-30.
63. Howbert JJ,
Lobb KL, Brown RF, Reel JK, Neel DA, Mason NR, Mendelsohn LG, Hodgkiss JP, Kelly
JS. A novel series of non-peptide CCK and gastrin antagonists: medicinal chemistry
and electrophysiological demonstration of antagonism. In: Dourish CT, Cooper
SJ, Iversen SD, Iversen LL (eds.) Multiple Cholecystokinin Receptors in the CNS. Oxford: Oxford University
Press, 1992; 28-37
64. Hoyer D, Bell
GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PPA, O'Carroll A-M, Patel YC,
Schonbrunn A, Taylor JE, Reisine T. Classification and nomenclature of somatostatin
receptors. Trends Pharmacol. Sci.
1995; 16: 86-88.
65. Hoyle CHV.
Neuropeptide families: evolutionary perspectives. Reg. Peptides 1998; 73: 1-33.
66. Hughes J,
Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD, Woodruff
GN. Cholekinoid antagonists, a new class of potent and specific CCK-B ligands
having potent anxiolytic activity. Proc.
Natl. Acad. Sci. 1990; 87: 6728-6732.
67. Ishihara T,
Shigemoto R, Mori K, Takahashi K, Nagata S. Functional expression and tissue
distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 1992; 8: 811-819.
68. Jirikowski
GF, Sanna PP, Bloom FE. mRNA coding oxytocin is present in axons of the hypothalamo-neurohypophyseal
tract. Proc. Natl. Acad. Sci. USA
1990; 87: 7400-7404.
69. Jirikowski
GF, Sanna PP, Maciejewski-Lenoir D, Bloom FE. Reversal of diabetes insipidus
in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA. Science 1992; 255: 996-998.
70. Johnson MD.
Synaptic glutamate release by postnatal rat serotonergic neurons in microculture.
Neuron 1994; 12: 433-442.
71. Kalra SP.
Appetite and body weight regulation: is it all in the brain? Neuron 1997; 19: 227-230.
72. Kaneko T,
Akiyama H, Nagatsu I, Mizuno N. Immunohistochemical demonstration of glutaminase
in catecholaminergic and serotonergic neurons of rat brain. Brain Res. 1990; 507: 141-154.
73. Kasakov L,
Ellis J, Kirkpatrick K, Milner P, Burnstock G. Direct evidence for concomitant
release of noradrenaline, adenosine 5'-triphosphate and neuropeptide Y from
sympathetic nerve supplying the guinea-pig vas deferens. J. Auton. Nerv. Syst. 1988; 22: 75-82.
74. Keith DE,
Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart
PL, Evans CJ, von Zastrow M. mu-Opioid receptor internalization: opiate drugs
have differential effects on a conserved endocytic mechanism in vitro and in
the mammalian brain. Mol. Pharmacol.
1998; 53: 377-384.
75. Kieffer BL,
Befort K, Gaveriaux-Ruff C, Hirth CG. The d-opioid receptor: Isolation of a cDNA by expression
cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 1992; 89: 12048-12052.
76. Kimura T,
Tanizawa O, Mori K, Brownstein MJ, Okayama H. Structure and expression of a
human oxytocin receptor. Nature 1992;
356: 526-529.
77. Kirchmair
R, Hogue-Angeletti R, Gutierrez J, Fischer-Colbrie R, Winkler H. Secretoneurin
- a neuropeptide generated in brain, adrenal medulla and other endocrine tissues
by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 1993; 53: 359-366.
78. Kitabgi P.
Neurotensin modulates dopamine neurotransmission at several levels along brain
dopaminergic pathway. Neurochem. Int.
1989; 14: 111-119.
79. Kluxen F-W,
Bruns C, Lübbert H. Expression cloning of a rat brain somatostatin receptor
cDNA. Proc. Natl. Acad. Sci. USA 1992;
89: 4612-4622.
80. Kopin AS,
Lee YM, McBride EW, Miller LJ, Lu M, Lin HY, L.F. K, Beiborn M. Expression cloning
and characterization of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. USA 1992; 89: 3605-3609.
81. Kramer MS,
Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G,
Snavely d, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison
T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams
AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NMJ. Distinct mechanism
for antidepressant activity by blockade of central substance P receptors. Science
1998; 281: 1640-1645.
82. Kreutzberg
GW. Repair and Regeneration of the Nervous
System. In: Nicholls JG (eds.) Berlin: Springer, 1982; 57-69
83. Kristensen
P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen
PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S. Hypothalamic CART is a new anorectic
peptide regulated by leptin. Nature
1998; 393: 72-76.
84. Kupfermann
I. Functional studies of cotransmission. Physiol.
Rev. 1991; 71: 683-732.
85. Lambert PD,
Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ. CART peptides in
the central control of feeding and interactions with neuropeptide Y. Synapse 1998; 29: 293-298.
86. Landry M,
Hökfelt T. Subcellular localization of preprogalanin messenger RNA in perikarya
and axons of hypothalamo-posthypophyseal magnocellular neurons: an in situ hybridization
study. Neuroscience 1998; 84: 897-912.
87. Larhammar
D, Blomqvist AG, Yee F, Jazin E, Yoo H, Wahlestedt C. Cloning and functional
expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J. Biol. Chem. 1992; 267: 10935-10938.
88. Larhammar
D, Söderberg C, Lundell I. Evolution of the neuropeptide Y family and its receptors.
Ann. N.Y. Acad. Sci. 1998; 839: 35-40.
89. Le Moine C,
Normand E, Bloch B. Phenotypical characterization of the rat striatal neurons
expressing the D1
dopamine receptor gene. Proc. Natl. Acad.
Sci. USA 1991; 88: 4205-4209.
90. Le Moine C,
Normand E, Guitteny AF, Fouque B, Teoule R, Bloch B. Dopamine receptor gene
expression by enkephalin neurons in the rat forebrain. Proc. Natl. Acad. Sci. USA 1990; 87: 230-234.
91. Lehman E,
Hanze J, Pauschinger M, Ganten D, Lang RE. Vasopressin mRNA in the neurolobe
of the rat pituitary. Neurosci. Lett.
1990; 111: 170-175.
92. Leibowitz
SF. Brain peptides and obesity: pharmacological treatment. Obes. Res. 1995; 3: 573S-589S.
93. Letter AA,
Merchant K, Gibb JW, Hanson GR. Effect of methamphetamine on neurotensin concentrations
in rat brain regions. J. Pharmacol. Exp.
Ther. 1987; 241: 443-447.
94. Levy A, Lightman
SL, Carter DA, Murphy D. The origin and regulation of posterior pituitary vasopressin
ribonucleic acid in osmotically stimulated rats. J. Neuroendocrinol. 1990; 2: 329-334.
95. Linguegila
E, Champigny G, Lazdunski M, Barbry P. Cloning of the amiloride-sensitive FMRFamide
peptide-gated sodium channel. Nature
1995; 378: 730-733.
96. Lipton MA,
DiMascio A, Killam KF (eds.). Psychopharmacology: A Generation of Progress.
New York: Raven Press, 1978.
97. Lolait S,
O'Carroll A-M, McBride OW, Konig M, Morel A, Brownstein MJ. Cloning and characterization
of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.
Nature 1992; 357: 336-339.
98. Lundberg JM.
Pharmacology of cotransmission in the autonomic nervous system: Integrative
aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric
oxide. Pharmacol. Rev. 1996; 48: 113-178.
99. Maciejewski-Lenoir
D, Jirikowski GF, Sanna PP, Bloom FE. Reduction of exogenous vasopressin RNA
poly(A) tail length increases its effectiveness in transiently correcting diabetes
insipidus in the Brattleboro rat. Proc.
Natl. Acad. Sci. USA 1993; 90: 1435-1439.
100. Mantyh PW,
DeMater E, Malhotra A, Ghilardi JR, Rogers SD, Mantyh CR, Liu H, Basbaum AI,
Vigna SR, Maggio JE, Simone DA. Receptor endocytosis and dendrite reshaping
in spinal neurons after somatosensory stimulation. Science 1995; 268: 1629-1632.
101. Marksteiner
J, Kirchmair R, Mahata SK, Mahata M, Fischer-Colbrie R, Hogue-Angeletti R, Saria
A, Winkler H. Distribution of secretoneurin, a peptide derived from secretogranin
II, in rat brain. An immunocytochemical and radioimmunological study. Neuroscience
1993; 54: 923-944.
102. Marksteiner
J, Saria A, Kirchmair R, Pycha R, Benesch H, Fischer-Colbrie R, Haring C, Maier
H, Ransmay G. Distribution of secretoneurin-like immunoreactivity in comparison
with substance P- and enkephalin-like immunoreactivities in various human forebrain
regions. Eur. J. Neurosci. 1993; 5:
1573-11585.
103. Marsh DJ,
Hollopeter G, Kafer KE, Palmiter RD. Role of the Y5 neuropeptide Y receptor
in feeding and obesity. Nature 1998;
4: 718-721.
104. Massot O,
Rousselle JC, Fillion MP, Grimaldi B, Cloez-Tayarani I, Fugelli A, Prudhomme
N, Seguin L, Rousseau B, Plantefol M, Hen R, Fillion G. 5-hydroxytryptamine-moduline,
a new endogenous cerebral peptide, controls the serotonergic activity via its
specific interaction with 5-hydroxytryptamine 1B/1D receptors. Mol.
Pharmacol. 1996; 50: 752-762.
105. Masu Y, Nakayama
K, Tamaki H, Harada Y, Kuno M, Nakanishi S. cDNA cloning of bovine substance-K
receptor through oocyte expression system. Nature 1987; 329: 836-838.
106. McCabe JT,
Lehman E, Chastrette N, Hanze J, Lang RE, Ganten D, Pfaff DW. Detection of vasopressin
mRNA in the neurointermediate lobe of the rat pituitary. Mol. Brain Res. 1990; 8: 325-329.
107. McLatchie
LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord
SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like
receptor. Nature 1998; 393: 333-339.
108. Meltzer H
(ed.). Psychopharmacology. The Third Generation of Progress. New York: Raven
Press, 1987.
109. Merchant
KM, Bush LG, Gibb JW, Hanson JR. Neurotensin-dopamine interactions in the substantia
nigra of the rat brain. J. Pharmacol.
Exp. Ther. 1990; 255: 775-780.
110. Merchant
KM, Gibb JW, Hanson GR. Role of dopamine D-1 and D-2 receptors in the regulation
of neurotensin systems of the neostriatum and the nucleus accumbens. Eur.J.Pharmacol.
1989; 160: 409-412.
111. Merchant
KM, Letter AA, Gibb JW, Hanson GR. Changes in the limbic neurotensin systems
induced by dopaminergic drugs. Eur. J.
Pharmacol. 1988; 153: 151-154.
112. Meunier J-C,
Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour J-L, Guillemot
J-C, Ferrare P, Monsarrat B, Mazaguil H, Vassart G, Parmentier M, Costentin
J. Isolation and structure of the endogenous agonist of opioid receptor-like
ORL1 receptor. Nature 1995;
377: 532-535.
113. Meyerhof
W, Darlison MG, Richter D. The elucidation of neuropeptide receptors and their
subtypes through the application of molecular biology. In: Hucho F (ed.) Neurotransmitter Receptors. Amsterdam:
Elsevier, 1993; 335-353
114. Meyerhof
W, Paust HJ, Schönrock C, Richter D. Cloning of a cDNA encoding a novel putative
G-protein-coupled receptor expressed in specific rat brain regions. DNA Cell Biol. 1991; 10: 689-694.
115. Meyerhof
W, Wolfsen I, Schönrock C, Fehr S, Richter D. Molecular cloning of a somatostatin-28
receptor and comparison of its expression pattern with that of a somatostatin-14
receptor in rat brain. Proc. Natl. Acad.
Sci. USA 1992;
116. Migaud M,
Roques BP, Durieux C. Evidence for a high affinity uptake for cholecystokinin
octapeptide (CCK8) in rat cortical synaptosomes. Eur. J. Neurosci. 1995; 7: 1074-1079.
117. Miki K, Fukuoka
T, Tokunaga A, Noguchi K. Calcitonin gene-related peptide increase in the rat
spinal dorsal horn and dorsal column nucleus following peripheral nerve injury:
up-regulation in a subpopulation of primary afferent sensory neurons. Neuroscience 1998; 82: 1243-1252.
118. Mohr E, Fehr
S, Richter D. Axonal transport of neuropeptide encoding mRNAs within the hypothalamo-hypophyseal
tract of rats. EMBO J. 1991; 10: 2419-2424.
119. Mohr E, Richter
D. Diversity of mRNAs in the axonal compartment of peptidergic neurons in the
rat. Eur. J. Neurosci. 1992; 4: 870-876.
120. Mohr E, Zhou
A, Thorn NA, Richter D. Rats with physically disconnected hypothalamo-pituitary
tracts no longer contain vasopressin-oxytocin gene transcripts in the posterior
pituitary lobe. FEBS Lett. 1990; 263: 332-336.
121. Morel A,
O'Caroll A-M, Brownstein MJ, Lolait SJ. Molecular cloning and expression of
a rat V1a arginine vasopressin receptor. Nature
1992; 356: 523-526.
122. Murphy D,
Levy A, Lightman S, Carter D. Vasopressin mRNA in the neural lobe of the pituitary:
dramatic accumulation in response to salt-loading. Proc. Natl. Acad. Sci. USA 1989; 86: 9002-9005.
123. Murphy TJ,
Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding
the vascular type-1 angiotensin II receptor. Nature 1991; 351: 233-236.
124. Nakaya Y,
Kaneko T, Shigemoto R, Nakanishi S, Mizuno N. Immunohistochemical localization
of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol. 1994; 347: 249-274.
125. Nelson LS,
Kim K, Memmott JE, Li C. FMRFamide-related gene family in the nematode, Caenorhabditis
elegans. Mol. Brain Res. 1998; 58:
103-111.
126. Nemeroff
CB. The interaction of neurotensin with dopaminergic pathways in the central
nervous system: basic neurobiology and implications for the pathogenesis and
treatment of schizophrenia. Psychoneuroendocrinol.
1986; 11: 15-37.
127. Nicholas
AP, Cuello AC, Goldstein M, Hökfelt T. Glutamate-like immunoreactivity in medulla
oblongata catecholamine/substance P neurons. NeuroReport 1990; 1: 235-238.
128. Nicholas
AP, Pieribone VA, Arvidsson U, Hökfelt T. Serotonin-, substance P- and glutamate/aspartate-like
immunoreactivities in medullo-spinal pathways of rat and primate. Neuroscience
1992; 48: 545-59.
129. Noguchi K,
Dubner R, De Leon M, Senba E, Ruda MA. Axotomy induces preprotachykinin gene
expression in a subpopulation of dorsal root ganglion neurons. J. Neurosci. Res. 1994; 37: 596-603.
130. O'Malley
Ss, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone
and coping skills therapy for alcohol depencence. A controlled study. Arch. Gen. Psychiatry 1992; 49: 881-887.
131. Okuda-Ashitaka
E, Minami T, Tachibana S, Yoshihara Y, Nishiuchi Y, Kimura T, Ito S. Nocistatin,
a peptide that blocks nociceptin action in pain transmission. Nature 1998; 392: 286-289.
132. Ollmann MM,
Wilson BD, Yang Y-K, Kerns JA, Chen Y, Gantz I, Barsh GS. Antagonism of central
melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278: 135-138.
133. Otsuka M,
Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 1993; 73: 229-308.
134. Palmiter
RD, Erickson JC, Hollopeter G, Baraban SC, Schwartz MW. Life without neuropeptide
Y. Recent Prog. Horm. Res. 1998; 53:
163-199.
135. Pedrazzini
T, Seydoux J, Küstner P, Aubert J-F, Grouzmann E, Beermann F, Brunner H-R. Cardiovascular
response, feeding behaviour and locomotor activity in mice lacking the NPY Y1
receptor. Nature 1998; 4: 722-726.
136. Penny GR,
Afsharpour S, Kitai ST. The glutamate decarboxylase-, leucine enkephalin-, methionine
enkephalin- and substance P-immunoreactive neurons in the neostriatum of the
rat and cat: evidence for partial population overlap. Neuroscience 1986; 17: 1011-1045.
137. Piccioli
P, Di Luzio A, Amann R, Schullgoi R, Azim Surani M, Donnerer J, Cattaneo A.
Neuroantibodies: Ectopic expression of a recombinant anti-substance P antibody
in the central nervous system of transgenic mice. Neuron 1995; 15: 373-384.
138. Reinscheid
RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK,
Langen H, Monsma FJJ, Civelli O. Orphanin FQ: a neuropeptide that activates
an opioidlike G protein-coupled receptor. Science
1995; 270: 792-794.
139. Rimland J,
Xin W, Sweetnam P, Saijoh K, Nestler EJ, Duman RS. Sequence and expression of
a neuropeptide Y receptor cDNA. Mol. Pharmacol.
1991; 40: 869-875.
140. Robertson
GS, Vincent SR, Fibigier HC. Striatonigral projection neurons contain D1 dopamine
receptor-activated c-fos. Brain Res.
1990; 523: 288-290.
141. Robertson
HA. Dopamine receptor interactions : some implications for the treatment of
Parkinson's disease. Trends Neurosci.
1992; 15: 201-206.
142. Roques BP,
Noble F. Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase
24.11 and aminopeptidase N) as potential new medications in the management of
pain and opioid addiction. NIDA Res. Monogr.
1995; 147: 104-145.
143. Sakurai T,
Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson
JA, Kozlowski GP, Wilson S, Arch JRS, Buckingham RE, Haynes AC, Carr SA, Annan
RS, McNulty DE, Liu W-S, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa
M. Orexins and orexin receptors: A family of hypothalamic neuropeptides and
G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-585.
144. Saria A,
Troger J, Kirchmair R, Fischer-Colbrie R, Hogue-Angeletti R, Winkler H. Secretoneurin
releases dopamine from rat striatal slices: a biological effect of a peptide
derived from secretogranin II (chromogranin C). Neuroscience 1993; 54: 1-4.
145. Sasaki K,
Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning
and expression of a complementory DNA encoding a bovine adrenal angiotensin
II type-1 receptor. Nature 1991; 351:
230-233.
146. Sawchenko
PE. Toward a new neurobiology of energy balance, appetite and obesity: The anatomists
weigh in. J. Comp. Neurol. 1998; 402:
435-441.
147. Schiffmann
SN, Vanderhaeghen JJ. Caffeine regulates neurotensin and cholecystokinin messenger
RNA expression in the rat striatum. Neuroscience 1993; 54: 681-689.
148. Schwartz
TW, U. G, Schambye HT, Hjorth SA. Molecular mechanism of action of non-peptide
ligands for peptide receptors. Current
Pharm. Design 1995; 1: 325-342.
149. Shehab SA,
Atkinson ME. Vasoactive intestinal polypeptide (VIP) increases in the spinal
cord after peripheral axotomy of the sciatic nerve originate from primary afferent
neurons. Brain Res. 1986; 372: 37-44.
150. Sherman TG,
Akil H, Watson SJ. The molecular biology of neuropeptides. Disc. Neurosci. 1989; 6: 1-58.
151. Shigemoto
R, Yokota Y, Tsuchida K, Nakanishi S. Cloning and expression of a rat neuromedin
K receptor cDNA. J. Biol. Chem. 1990;
265: 623-628.
152. Shinmi O,
Kimura S, Yoshizawa T, Sawamura T, Uchiyama Y, Sugita Y, Kanazawa I, Yanagisawa
M, Goto K, Masaki T. Presence of endothelin-1 in porcine spinal cord: isolation
and sequence determination. Biochem. Biophys.
Res. Commun. 1989; 162: 340-346.
153. Shutter JR,
Graham M, Kinsey AC, Scully S, Lüthy R, Stark KL. Hypothalamic expression of
ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant
mice. Genes Develop. 1997; 11: 593-602.
154. Sneddon P,
Westfall DP. Pharamcological evidence that adenosine triphosphate and noradrenaline
are cotransmitters in the guinea-pig vas deferens. J. Physiol. 1984; 347: 561-580.
155. Snider RM,
Constantine JW, Lowe IJ, Longo KP, Lebel WS, Woody HA, Drozda SE, Desai MC,
Vinick FJ, Spencer RW, Hess H-J. A potent nonpeptide antagonist of the substance
P (NK1) receptor. Science 1991; 251:
435-437.
156. Sreedharan
SP, Robichon A, Peterson KE, Goetzl EJ. Cloning and expression of the human
vasoactive intestinal peptide receptor. Proc.
Natl. Acad. Sci. USA 1991; 1: 4986-4990.
157. Stein CA,
Cheng Y-C. Antisense oligonucleotides as therapeutic agents - Is the bullet
really magical? Science 1993; 261:
1004-1012.
158. Strand F.
Neuropeptides: Regulators of Physiological Processes. Cambridge: The MIT Press,
1999.
159. Strand FL,
Rose KJ, Zuccarelli LA, Kume J. Neuropeptide hormones as neurotrophic factors.
Physiol. Rev. 1991; 71: 1017-1037.
160. Straub RE,
Frech GC, Joho RH, Gershengorn MC. Expression cloning of a cDNA encoding the
mouse pituitary thyrotropin-releasing hormone receptor. Proc. Natl. Acad. Sci. USA 1990; 87: 9514-9518.
161. Sudoh T,
Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain.
Nature 1988; 332: 78-81.
162. Takeda Y,
Chou KB, Takeda J, Sachais BS, Krause JE. Molecular cloning, structural characterization
and functional expression of the human substance P receptor. Biochem. Biophys. Res. Commun. 1991; 179:
1232-1240.
163. Tanaka K,
Masu M, Nakanishi S. Structure and functional expression of the cloned rat neurotensin
receptor. Neuron 1990; 4: 847-854.
164. Thiele TE,
Marsh DJ, Marie LS, Bernstein IL, Palmiter RD. Ethanol consumption and resistance
are inversely reltated to neuropeptide Y levels. Nature 1998; 396: 366-369.
165. Tohyama M.
An overview of the ontogeny of neurotransmitters and neuromodulators in the
central nervous system. In: Björklund A, Hökfelt T, Tohyama M (eds.) Handbook of Chemical Neuroanatomy. Vol. 10.
Ontogeny of 'Transmitters and Peptides in the CNS. Amsterdam: Elsevier, 1992; 647-650
166. Trembleau
A, Morales M, Bloom FE. Aggregation of vasopressin mRNA in a subset of axonal
swellings of the median eminence and posterior pituitary: Light and electron
microscopic evidence. J. Neurosci.
1994; 14: 39-53.
167. Verhage M,
McMahon HT, Ghijsen WEJM, Boomsma F, Scholten G, Wiegant VM, Nicholls DG. Differential
release of amino acids, neuropeptides, and catecholamines from isolated nerve
terminals. Neuron 1991; 6: 517-524.
168. Volpicelli
JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol
dependence. Arch. Gen. Psychiatry
1992; 49: 876-880.
169. Wachi M,
Okuda M, Togashi S, Miyashita O, Wakahoi T. Effects of methamphetamine administration
on brain neurotensin-like immunoreactivity in rats. Neurosci. Lett. 1987; 78: 222-226.
170. Wada E, Way
J, Shapira H, Kusano K, Lebacq-Verheyden AM, Coy D, Jensen R, Battey J. cDNA
cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring
bombesin receptor. Neuron 1991; 6:
421-430.
171. Wahlestedt
C. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharm. Sci. 1994; 151: 42-46.
172. Wakisaka
S, Kajander KC, Bennett GJ. Increased neuropeptide (NPY)-like immunoreactivity
in rat sensory neurons following peripheral axotomy. Neurosci. Lett. 1991; 124: 200-203.
173. Wang JB,
Imai Y, Eppler CM, Gregor P, Spivak CE, Uhl GR. µ opiate receptor: cDNA cloning
and expression. Proc. Natl. Acad. Sci.
USA 1993; 90: 10230-10234.
174. Wank SA,
Harkins R, Jensen RT, Shapira H, De Weerth A, Slattery T. Purification, molecular
cloning, and functional expression of the cholecystokinin receptor from rat
pancreas. Proc. Natl. Acad. Sci. USA
1992; 89: 3125-3129.
175. Wiesenfeld-Hallin
Z, Bartfai T, Hökfelt T. Galanin in sensory neurons in the spinal cord. Front. Neuroendocrinol. 1992; 13: 319-343.
176. Woods SC,
Seeley RJ, Porte DJ, Schwartz MW. Signals that regulate food intake and energy
homeostasis. Science 1998; 280: 1378-1383.
177. Xu Z-Q, Shi
T-J, Hökfelt T. Expression of galanin and galanin receptor in several sensory
systems and bone anlage of rat embryos. Proc. Natl. Acad. Sci. USA 1996; 93: 14901-14905.
178. Xu Z-QD,
Shi T-JS, Hökfelt T. Galanin/GMAP- and NPY-like immunoreactivities in locus
coeruleus and noradrenergic nerve terminals in the hippocampal formation and
cortex with notes on the galanin-R1 and - R2 receptors. J. Comp. Neurol. 1998; 392: 227-252.
179. Xu Z-QD,
Zhang X, Pieribone VA, Grillner S, Hökfelt T. Galanin-5-hydroxytryptamine interactions:
Electrophysiological, immunohistochemical and in situ hybridization studies
on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience
1998; 87: 79-94.
180. Yamada Y,
Post SR, Wang K, Tager HS, Bell GI, Seino S. Cloning and functional characterization
of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal
tract, and kidney. Proc. Natl. Acad. Sci. USA 1992; 89: 251-255.
181. Yasuda K,
Raynor K, Kong H, Breder C, Takeda J, Reisine T, Bell GI. Cloning and functional
comparison of k and d opioid receptors from mouse brain. Proc.
Natl. Acad. Sci. USA 1993; 90: 6736-6740.
182. Yokota Y,
Sasai Y, Tanaka K, Fujiwara T, Tsuchida K, Shigemoto R, Kakizuka A, Ohkubo H,
Nakanishi S. Molecular characterization of a functional cDNA for rat substance
P receptor. J. Biol. Chem. 1989; 264:
17649-17652.
183. Young WSI.
In situ hybridization histochemistry. In: Björklund A, Hökfelt T, Wouterlood
FG, Van den Pol AN (eds.) Handbook of
Chemical Neuroanatomy, Vol. 8. Analysis
of Neuronal Microcircuits and Synaptic Interactions. Amsterdam: Elsevier, 1990; 481-512
184. Zadina JE,
Hackler L, Ge L-J, Kastin AJ. A potent and selective endogenous agonist for
the m-opiate
receptor. Nature 1997; 386: 499-502.
185. Zhang X,
Dagerlind Å, Elde RP, Castel M-N, Broberger C, Wiesenfeld-Hallin Z, Hökfelt
T. Marked increase in cholecystokinin B receptor messenger RNA levels in rat
dorsal root ganglia after peripheral axotomy. Neuroscience 1993; 57: 227-233.
186. Zhang X,
Shi T-J, Holmberg K, Landry M, Huan W, Xiao H, Ju G, Hökfelt T. Expression and
regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia.
Proc. Natl. Acad. Sci. USA 1997; 94: 729-734.
187. Zhang X,
Wiesenfeld-Hallin Z, Hökfelt T. Effect of peripheral axotomy on expression of
neuropeptide Y receptor mRNA in rat lumbar dorsal root ganglia. Eur. J. Neurosci. 1994; 6: 43-57.
188. Zhang Y,
Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of
the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
189. Zhao D, Yang
J, Jones KE, Gerald C, Suzuki Y, Hogan PG, Chin WW, Tashijian AHJ. Molecular
cloning of a complementary deoxyribonucleic acid encoding the thyrotropin-releasing
hormone receptor and regulation of its messenger ribonucleic acid in rat GH
cells. Endocrinology 1992; 130: 3529-3536.
190. Zimmer A, Zimmer AM, Baffi J, Usdin T, Reynolds K, Konig M, Palkovits M, Mezey E. Hypoalgesia in mice with a targeted deletion of the tachkinin 1 gene. Proc. Natl. Acad. Sci. USA 1998; 95: 2630-2635.
published 2000